The inconvenience due to women’s monthly bleeding (ISY) survey: a study of premenstrual symptoms among 5728 women in Europe

References

• Halbreich U. The diagnosis of premenstrual syndromes and premenstrual dysphoric disorder-clinical procedures and research perspectives. Gynecol Endocrinol. 2004;19:320–334.
   PubMed Web of Science ®Google Scholar
• Biggs WS, Demuth RH. Premenstrual syndrome and premenstrual dysphoric disorder. Am Fam Physician. 2011;84:918–924.
   PubMed Web of Science ®Google Scholar
• Yonkers KA, O’Brien PM, Eriksson E. Premenstrual syndrome. Lancet. 2008;371:1200–1210.
   PubMed Web of Science ®Google Scholar
• Braverman PK. Premenstrual syndrome and premenstrual dysphoric disorder. J Pediatr Adolesc Gynecol. 2007;20:3.
   PubMed Web of Science ®Google Scholar
• Johnson SR. Premenstrual syndrome, premenstrual dysphoric disorder, and beyond: a clinical primer for practitioners. Obstet Gynecol. 2004;104:845–859.
   PubMed Web of Science ®Google Scholar
• Schmidt PJ, Nieman LK, Danaceau MA, et al. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med. 1998;338:209–216.
   PubMed Web of Science ®Google Scholar
• Rubinow DR, Schmidt PJ. Gonadal steroid regulation of mood: the lessons of premenstrual syndrome. Front Neuroendocrinol. 2006;27:210–216.
   PubMed Web of Science ®Google Scholar
• Lundin C, Danielsson KG, Bixo M, et al. Combined oral contraceptive use is associated with both improvement and worsening of mood in the different phases of the treatment cycle-A double-blind, placebo-controlled randomized trial. Psychoneuroendocrinology. 2017;76:135–143.
   PubMed Web of Science ®Google Scholar
• Lukes AS, Baker J, Eder S, et al. Daily menstrual blood loss and quality of life in women with heavy menstrual bleeding. Womens Health (Lond). 2012;8:503–511.
   PubMedGoogle Scholar
• Sternfeld B, Swindle R, Chawla A, et al. Severity of premenstrual symptoms in a health maintenance organization population. Obstet Gynecol. 2002;99:1014–1024.
   PubMed Web of Science ®Google Scholar
• Coffee AL, Kuehl TJ, Willis S, et al. Oral contraceptives and premenstrual symptoms: comparison of a 21/7 and extended regimen. Am J Obstet Gynecol. 2006;195:1311–1319.
   PubMed Web of Science ®Google Scholar
• Witjes H, Creinin MD, Sundström-Poromaa I, et al. Comparative analysis of the effects of nomegestrol acetate/17 β-estradiol and drospirenone/ethinylestradiol on premenstrual and menstrual symptoms and dysmenorrhea. Eur J Contracept Reprod Health Care. 2015;20:296–307.
   PubMed Web of Science ®Google Scholar
• Vandever MA, Kuehl TJ, Sulak PJ, et al. Evaluation of pituitary-ovarian axis suppression with three oral contraceptive regimens. Contraception. 2008;77:162–170.
   PubMed Web of Science ®Google Scholar
• Andersch B, Wendestam L, Hahn L, et al. Premenstrual complaints. 1. Prevalence of premenstrual symptoms in a Swedish urban population. J Psychosom Obstet Gynaecol. 1986;5:39–49.
   Google Scholar
• Cheng SH, Shih CC, Yang YK, et al. Factors associated with premenstrual syndrome - a survey of new female university students. Kaohsiung J Med Sci. 2013;29:100–105.
   PubMed Web of Science ®Google Scholar
• Takeda T, Tasaka K, Sakata M, et al. Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in Japanese women. Arch Womens Ment Health. 2006;9:209–212.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Fiala C, Chabbert-Buffet N, et al. Women’s preferences for menstrual bleeding frequency: results of the Inconvenience Due to Women’s Monthly Bleeding (ISY) survey. Eur J Contracept Reprod Health Care. 2016;21:242–250.
   PubMed Web of Science ®Google Scholar
• Ross C, Coleman G, Stojanovska C. Prospectively reported symptom change across the menstrual cycle in users and non-users of oral contraceptives. J Psychosom Obstet Gynaecol. 2003;24:15–29.
   PubMed Web of Science ®Google Scholar
• Natale V, Albertazzi P. Mood swings across the menstrual cycle: a comparison between oral contraceptive users and non-users. Biol Rhythm Res. 2006;37:489–495.
   Web of Science ®Google Scholar
• Marcinko I, Torjanac M. The Difference in the severity of premenstrual symptoms between users and non-users of oral contraceptives. Coll Antropol. 2015;39:855–862.
   PubMedGoogle Scholar
• Boyle GJ, Grant AF. Prospective versus retrospective assessment of menstrual cycle symptoms and moods: role of attitudes and beliefs. J Psychopathol Behav Assess. 1992;14:307–321.
   Web of Science ®Google Scholar
• Graham CA, Sherwin BB. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive. J Psychosom Res. 1992;36:257–266.
   PubMed Web of Science ®Google Scholar
• Mansour D. Experiences with Yasmin: the acceptability of a novel oral contraceptive and its effect on well-being. Eur J Contracept Reprod Health Care. 2002;7:35–43.
   PubMed Web of Science ®Google Scholar
• Bitzer J, Banal-Silao MJ, Ahrendt HJ, et al. Hormone withdrawal-associated symptoms with ethinylestradiol 20 μg/drospirenone 3 mg (24/4 regimen) versus ethinylestradiol 20 μg/desogestrel 150 μg (21/7 regimen). Int J Womens Health. 2015;7:501–509.
   PubMed Web of Science ®Google Scholar
• Marriott A, Faragher EB. An assessment of psychological state associated with the menstrual cycle in users of oral contraception. J Psychosom Res. 1986;30:41–47.
   PubMed Web of Science ®Google Scholar
• Graham CA, Sherwin BB. The relationship between retrospective premenstrual symptom reporting and present oral contraceptive use. J Psychosom Res. 1987;31:45–53.
   PubMed Web of Science ®Google Scholar
• Yuk VJ, Cumming CE, Fox EE, et al. Frequency and severity of premenstrual symptoms in women taking birth control pills. Gynecol Obstet Invest. 1991;31:42–45.
   PubMed Web of Science ®Google Scholar
• Edelman A, Micks E, Gallo MF, et al. Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception. Cochrane Database Syst Rev. 2014;7:CD004695.
   PubMed Web of Science ®Google Scholar
• Willis S. Greater inhibition of the pituitary–ovarian axis in oral contraceptive regimens with a shortened hormone-free interval. Contraception. 2006;74:100–103.
   PubMed Web of Science ®Google Scholar
• Hart WG, Coleman GJ, Russell JWA. Assessment of premenstrual symptomatology: a re-evaluation of the predictive validity of self-report. J Psychosom Res. 1987;31:185–190.
   PubMed Web of Science ®Google Scholar
• Metcalf MG, Livesey JH, Wells JE, et al. Physical symptom cyclicity in women with and without the premenstrual syndrome. J Psychosom Res. 1990;34:203–213.
   PubMed Web of Science ®Google Scholar
• Halbreich U, Endicott J, Schacht S, et al. The diversity of premenstrual changes as reflected in the premenstrual assessment form. Acta Psychiatr Scand. 1982;65:46–65.
   PubMed Web of Science ®Google Scholar
• Woods NF, Most A, Dery GK. Toward a construct of perimenstrual distress. Res Nurs Health. 1982; 5:123–136.
   PubMed Web of Science ®Google Scholar
• van den Akker O, Steptoe A. The pattern and prevalence of symptoms during the menstrual cycle. Br J Psychiatry. 1985;147:164–169.
   PubMed Web of Science ®Google Scholar
• Blanchard K. Life without menstruation. Obstet Gynaecol. 2003;5:34–37.
   Google Scholar
• Thomas SL, Ellertson C. Nuisance or natural and healthy: should monthly menstruation be optional for women? Lancet. 2000;355:922–924.
   PubMed Web of Science ®Google Scholar
• Kaunitz AM. Menstruation: choosing whether. and when. Contraception. 2000;62:277–284.
   Google Scholar
• Hillard PA. Menstrual suppression: current perspectives. Int J Womens Health. 2014;6:631–637.
   PubMedGoogle Scholar
• Ferrero S, Abbamonte LH, Giordano M, et al. What is the desired menstrual frequency of women without menstruation-related symptoms? Contraception. 2006;73:537–541.
   PubMed Web of Science ®Google Scholar
• Sulak PJ, Willis S, Kuehl T, et al. Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval. Headache. 2007;47:27–37.
   PubMed Web of Science ®Google Scholar
• Vercellini P, Crosignani P, Somigliana E, et al. 'Waiting for Godot': a commonsense approach to the medical treatment of endometriosis. Hum Reprod. 2011;26:3–13.
   PubMed Web of Science ®Google Scholar